# AXIM Biotechnologies, Inc. (AXIM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AXIM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -100.7K | $ -825.9K | $ 7.55M | $ -10.43M |
| 2024 | $ 74.1K | $ -3.69M | $ -901.7K | $ 6.64M | $ -10.42M |
| 2023 | $ 43.0K | $ -10.87M | $ -1.11M | $ 5.66M | $ -7.63M |
| 2022 | $ 9.9K | $ -6.97M | $ -2.28M | $ 5.66M | $ -4.83M |
| 2021 | $ 71.9K | $ -19.06M | $ -3.02M | $ 6.72M | $ -2.34M |
| 2020 | $ 0 | $ -8.17M | $ -4.22M | $ 6.31M | $ 1.57M |
| 2019 | $ 1.03M | $ -8.32M | $ -6.48M | $ 6.10M | $ -6.76M |
| 2018 | $ 258.3K | $ -8.92M | $ -6.40M | $ 5.87M | $ -6.08M |
| 2017 | $ 64.1K | $ -5.62M | $ -4.15M | $ 6.40M | $ -6.28M |
| 2016 | $ 64.7K | $ -7.99M | $ -1.78M | $ 1.77M | $ -2.37M |
| 2015 | $ 69.0K | $ -14.17M | $ -2.18M | $ 1.45M | $ -1.70M |
| 2014 | $ 0 | $ -823.7K | $ -479.0K | $ 1.05M | $ -580.7K |
| 2013 | $ 46.2K | $ -111.5K | $ -47.0K | $ 50.0K | $ -93.9K |
| 2012 | $ 62.6K | $ -21.5K | $ -41.7K | $ 50.0K | $ -4.7K |
| 2011 | $ 14.7K | $ -4.1K | $ 6.0K | $ 0 | $ 10.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.72 |
| Liabilities / Eq | -1.31 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/AXIM.md)
- [Charts](https://sponda.capital/en/AXIM/charts.md)
- [Compare](https://sponda.capital/en/AXIM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.